Federal Register / Vol. 89, No. 5 / Monday, January 8, 2024 / Notices 987 

increase in each of the rates in sections 

1114, 1115(1), and 1162 of title 38, 

United States Code. VA is required to 

increase these benefit rates by the same 

percentage as increases in the benefit 

amounts payable under title II of the 

Social Security Act. The increased rates 

are required to be published in the 

Federal Register. 

The Social Security Administration 

has announced that there will be a 3.2% 

cost-of-living increase in Social Security 

benefits for 2024. Therefore, applying 

the same percentage, the following rates 

for VA’s compensation program became 

effective on December 1, 2023: 

Monthly rate 

Disability Compensation 

[38 U.S.C. 1114] 

Disability evaluation percentage: 

10 ......................................... $171.23 

20 ......................................... 338.49 

30 ......................................... 524.31 

40 ......................................... 755.28 

50 ......................................... 1,075.16 

60 ......................................... 1,361.88 

70 ......................................... 1,716.28 

80 ......................................... 1,995.01 

90 ......................................... 2,241.91 

100 ....................................... 3,737.85 

38 U.S.C. 1114(k) through (t)): 

38 U.S.C. 1114(k) ................ 132.74 

38 U.S.C. 1114(l) ................. 4,651.06 

38 U.S.C. 1114(m) .............. 5,132.92 

38 U.S.C. 1114(n) ............... 5,839.08 

38 U.S.C. 1114(o) ............... 6,526.64 

38 U.S.C. 1114(p) ............... 6,526.64 

38 U.S.C. 1114(r) ................ 2,799.43; 4,170.59 

38 U.S.C. 1114(s) ................ 4,183.85 

38 U.S.C. 1114(t) ................ 4,170.59 

Additional Compensation for Dependents 

[38 U.S.C. 1115(1)] 

38 U.S.C. 1115(1)(A) .............. 208.40 

38 U.S.C. 1115(1)(B) .............. 361.02; 103.55 

38 U.S.C. 1115(1)(C) .............. 139.37; 103.55 

38 U.S.C. 1115(1)(D) .............. 167.26 

38 U.S.C. 1115(1)(E) .............. 399.54 

38 U.S.C. 1115(1)(F) .............. 334.49 

Clothing Allowance 

[38 U.S.C. 1162] 

$999.51 per year. 

Signing Authority 

Denis McDonough, Secretary of 

Veterans Affairs, approved and signed 

this document on January 2, 2024, and 

authorized the undersigned to sign and 

submit the document to the Office of the 

Federal Register for publication 

electronically as an official document of 

the Department of Veterans Affairs. 

Luvenia Potts, 

Regulation Development Coordinator, Office 

of Regulation Policy & Management, Office 

of the Secretary, Department of Veterans 

Affairs. 

[FR Doc. 2024–00160 Filed 1–5–24; 8:45 am] 

BILLING CODE 8320–01–P 

DEPARTMENT OF VETERANS 

AFFAIRS 

Joint Biomedical Laboratory Research 

and Development and Clinical Science 

Research and Development Services 

Scientific Merit Review Board, Notice 

of Meeting 

The Department of Veterans Affairs 

(VA) gives notice under the Federal 

Advisory Committee Act, 5 U.S.C. 

ch.10, that a meeting of the Joint 

Biomedical Laboratory Research and 

Development and Clinical Science 

Research and Development Services 

Scientific Merit Review Board will be 

held January 30, 2024, via Webex. The 

meeting will be held between 3 p.m. 

and 5 p.m. EDT. The meeting will be 

closed to the public from 3:30–5 p.m. 

EDT for the discussion, examination 

and reference to the research 

applications and scientific review. 

Discussions will involve reference to 

staff and consultant critiques of research 

proposals. Discussions will deal with 

scientific merit of each proposal and 

qualifications of personnel conducting 

the studies, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Additionally, premature disclosure of 

research information could significantly 

obstruct implementation of proposed 

agency action regarding the research 

proposals. As provided by Public Law 

92–463 subsection 10(d), as amended by 

Public Law 94–409, closing the 

committee meeting is in accordance 

with 5 U.S.C. 552b(c) (6) and (9)(B). 

The objective of the Board is to 

provide for the fair and equitable 

selection of the most meritorious 

research projects for support by VA 

research funds and to offer advice for 

research program officials on program 

priorities and policies. The ultimate 

objective of the Board is to ensure the 

high quality and mission relevance of 

VA’s legislatively mandated Biomedical 

Laboratory and Clinical Science 

Research and Development programs. 

Board members advise the Directors 

of the Biomedical Laboratory and 

Clinical Sciences Research Services and 

the Chief Research and Development 

Officer on the scientific and technical 

merit, the mission relevance, and the 

protection of human subjects of 

Biomedical Laboratory and Clinical 

Sciences Research and Development 

proposals. The Board does not consider 

grants, contracts, or other forms of 

extramural research. 

Members of the public may attend the 

open portion of the meeting. The time 

limited agenda does not enable public 

comments or presentations. To attend 

the open portion of the meeting (3–3:30 

p.m. EDT), the public may join by 

dialing the phone number 1–404–397– 

1596 and entering the meeting number 

(access code): 2763 451 0764. 

Written public comments must be 

sent to Michael R. Burgio, Ph.D., 

Designated Federal Officer, Office of 

Research and Development, Department 

of Veterans Affairs (14RD), 810 Vermont 

Avenue NW, Washington, DC 20420, or 

to Michael.Burgio@va.gov at least five 

days before the meeting via the email 

listed above. The written public 

comments will be shared with the board 

members. The public may not attend the 

closed portion of the meeting as 

disclosure of research information could 

significantly obstruct implementation of 

proposed agency action regarding the 

research proposals (Pub. L. 92–463 

subsection 10(d), as amended by Pub. L. 

94–409, closing the committee meeting 

is in accordance with title 5 U.S.C. 

552b(c)(6) and (9)(B). 

Dated: January 3, 2024. 

LaTonya L. Small, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2024–00162 Filed 1–5–24; 8:45 am] 

BILLING CODE P 


ddrumheller on DSK120RN23PROD with NOTICES1